- Home
- ACIU vs ZVIA Comparison
ACIU vs ZVIA Comparison
Compare ACIU & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIU | ZVIA |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 193.4M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ACIU | ZVIA |
|---|---|---|
| Price | $3.68 | $1.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $10.00 | $4.89 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 11-04-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,482,957.00 | ★ $162,849,000.00 |
| Revenue This Year | N/A | $7.60 |
| Revenue Next Year | $644.42 | $6.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.17 |
| 52 Week Low | $1.43 | $1.82 |
| 52 Week High | $4.00 | $4.99 |
Technical Indicators
Market Signals| Indicator | ACIU | ZVIA |
|---|---|---|
| Relative Strength Index (RSI) | 64.73 | 26.31 |
| Support Level | $3.09 | $1.82 |
| Resistance Level | $3.73 | $2.34 |
| Average True Range (ATR) | 0.21 | 0.13 |
| MACD | 0.06 | -0.06 |
| Stochastic Oscillator | 91.86 | 11.56 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.